Remogliflozin Etabonate + Teneligliptin

Introduction

Remogliflozin Etabonate + Teneligliptin is a fixed-dose combination medication used in the treatment of type 2 diabetes mellitus. It helps control high blood sugar levels in adults when diet and exercise alone are not enough. Remogliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor, while Teneligliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. Together, they provide a dual mechanism to enhance glucose control, reduce HbA1c levels, and lower the risk of diabetes-related complications.

Uses of Remogliflozin Etabonate + Teneligliptin

• Management of type 2 diabetes mellitus
• Improves blood glucose control in adults
• Used when single therapy is insufficient
• Reduces the risk of cardiovascular complications in diabetic patients

How Remogliflozin Etabonate + Teneligliptin Works

Remogliflozin inhibits SGLT2 in the kidneys, reducing glucose reabsorption and increasing urinary glucose excretion. Teneligliptin blocks DPP-4 enzymes, prolonging the action of incretin hormones that stimulate insulin release and suppress glucagon levels. This dual action improves overall glycemic control.

Benefits of Remogliflozin Etabonate + Teneligliptin

• Effective dual therapy for type 2 diabetes
• Improves HbA1c levels
• Reduces postprandial and fasting blood sugar
• Aids in weight loss in some patients
• Lowers risk of hypoglycemia compared to other antidiabetics

How to Take Remogliflozin Etabonate + Teneligliptin

This medication should be taken orally once or twice daily as prescribed by your doctor, usually before or after meals. It should be taken at the same time every day for best results. Do not skip doses or stop medication without consulting your healthcare provider.

Type of Dosage Available

• Tablets
• Film-coated tablets (various strengths)

Side Effects of Remogliflozin Etabonate + Teneligliptin

• Urinary tract infections
• Increased urination
• Nausea
• Hypoglycemia (when used with insulin or sulfonylureas)
• Headache
• Dehydration
• Weight loss

Safety Advice

• Not recommended for patients with type 1 diabetes
• Use with caution in patients with kidney or liver impairment
• Stay hydrated to avoid dehydration
• Regularly monitor blood sugar and kidney function
• Avoid alcohol while on this medication
• Not suitable during pregnancy or breastfeeding unless advised by a doctor

Frequently Asked Questions (FAQs)

Q: What is Remogliflozin Etabonate + Teneligliptin used for?
A: It is used for managing blood sugar levels in adults with type 2 diabetes mellitus.

Q: Can this combination cause hypoglycemia?
A: It has a low risk of hypoglycemia unless combined with other medications like insulin or sulfonylureas.

Q: How should I take this medication?
A: Take the tablet as prescribed by your doctor, usually once or twice daily with or without food.

Q: Are there any dietary restrictions while using this medicine?
A: Maintain a balanced diet and follow your doctor's dietary advice to support blood sugar control.

Q: Can I take it with other diabetes medications?
A: Yes, but only under medical supervision to avoid overlapping effects or interactions.